Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia
There is a paucity of literature describing de-escalation techniques in patients with polymicrobial infections with one offending organism being methicillin-susceptible Staphylococcus aureus (MSSA) being treated with β-lactam therapy. The purpose of this study is to determine treatment outcomes for...
Main Authors: | Laila M. Najia, Eric Pyles, Arnaldo Lopez-Ruiz, Bibidh Subedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Advances in Pharmacological and Pharmaceutical Sciences |
Online Access: | http://dx.doi.org/10.1155/2023/7684613 |
Similar Items
-
Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
by: Bo-Guen Kim, et al.
Published: (2023-05-01) -
Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
by: Najmul Karim, et al.
Published: (2022-08-01) -
SUSCEPTIBILITIES OF ESBL-PRODUCING ENTEROBACTERIAECEAE TO ERTAPENEM, MEROPENEM AND PIPERACILLIN-TAZOBACTAM
by: Kinal Shah, et al.
Published: (2012-06-01) -
A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP)
by: Serrano-Mayorga, CC, et al.
Published: (2024) -
A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP)
by: Cristian C. Serrano-Mayorga, et al.
Published: (2024-06-01)